Literature DB >> 21776971

Native-state interconversion of a metamorphic protein requires global unfolding.

Robert C Tyler1, Nathan J Murray, Francis C Peterson, Brian F Volkman.   

Abstract

Lymphotactin (Ltn) is a unique chemokine that under physiological solution conditions displays large-scale structural heterogeneity, defining a new category of "metamorphic proteins". Previous Ltn studies have indicated that each form is required for proper function, but the mechanism of interconversion remains unknown. Here we have investigated the temperature dependence of kinetic rates associated with interconversion and unfolding by stopped-flow fluorescence to determine transition-state free energies. Comparisons of derived thermodynamic parameters revealed striking similarities between interconversion and protein unfolding. We conclude that Ltn native-state rearrangement proceeds by way of a large-scale unfolding process rather than a unique intermediate structure.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21776971      PMCID: PMC3160782          DOI: 10.1021/bi200750k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

Review 1.  Chemokines: a new classification system and their role in immunity.

Authors:  A Zlotnik; O Yoshie
Journal:  Immunity       Date:  2000-02       Impact factor: 31.745

2.  Thermodynamics and kinetics of a folded-folded' transition at valine-9 of a GCN4-like leucine zipper.

Authors:  D A d'Avignon; G L Bretthorst; M E Holtzer; A Holtzer
Journal:  Biophys J       Date:  1999-05       Impact factor: 4.033

3.  Titration properties and thermodynamics of the transition state for folding: comparison of two-state and multi-state folding pathways.

Authors:  Y J Tan; M Oliveberg; A R Fersht
Journal:  J Mol Biol       Date:  1996-11-29       Impact factor: 5.469

4.  Thermodynamic properties of the transition state for the rate-limiting step in the folding of the alpha subunit of tryptophan synthase.

Authors:  X Chen; C R Matthews
Journal:  Biochemistry       Date:  1994-05-24       Impact factor: 3.162

5.  An engineered second disulfide bond restricts lymphotactin/XCL1 to a chemokine-like conformation with XCR1 agonist activity.

Authors:  Robbyn L Tuinstra; Francis C Peterson; E Sonay Elgin; Adam J Pelzek; Brian F Volkman
Journal:  Biochemistry       Date:  2007-02-16       Impact factor: 3.162

6.  Defining folding and unfolding reactions of apocytochrome b5 using equilibrium and kinetic fluorescence measurements.

Authors:  S Manyusa; D Whitford
Journal:  Biochemistry       Date:  1999-07-20       Impact factor: 3.162

7.  Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.

Authors:  Amanda E I Proudfoot; Tracy M Handel; Zoë Johnson; Elaine K Lau; Patricia LiWang; Ian Clark-Lewis; Frédéric Borlat; Timothy N C Wells; Marie H Kosco-Vilbois
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

8.  Lymphotactin: how a protein can adopt two folds.

Authors:  Carlo Camilloni; Ludovico Sutto
Journal:  J Chem Phys       Date:  2009-12-28       Impact factor: 3.488

9.  Identification and characterization of a glycosaminoglycan recognition element of the C chemokine lymphotactin.

Authors:  Francis C Peterson; E Sonay Elgin; Timothy J Nelson; Fuming Zhang; Theresa J Hoeger; Robert J Linhardt; Brian F Volkman
Journal:  J Biol Chem       Date:  2004-01-05       Impact factor: 5.157

10.  Low-temperature unfolding of a mutant of phage T4 lysozyme. 2. Kinetic investigations.

Authors:  B L Chen; W A Baase; J A Schellman
Journal:  Biochemistry       Date:  1989-01-24       Impact factor: 3.162

View more
  19 in total

1.  NMR in the Analysis of Functional Chemokine Interactions and Drug Discovery.

Authors:  Joshua J Ziarek; Brian F Volkman
Journal:  Drug Discov Today Technol       Date:  2012

2.  Production of Recombinant Chemokines and Validation of Refolding.

Authors:  Christopher T Veldkamp; Chad A Koplinski; Davin R Jensen; Francis C Peterson; Kaitlin M Smits; Brittney L Smith; Scott K Johnson; Christina Lettieri; Wallace G Buchholz; Joyce C Solheim; Brian F Volkman
Journal:  Methods Enzymol       Date:  2015-11-14       Impact factor: 1.600

Review 3.  Protein conformational switches: from nature to design.

Authors:  Jeung-Hoi Ha; Stewart N Loh
Journal:  Chemistry       Date:  2012-06-11       Impact factor: 5.236

4.  Structural insight into the evolution of a new chemokine family from zebrafish.

Authors:  Deepa Rajasekaran; Chengpeng Fan; Wuyi Meng; James W Pflugrath; Elias J Lolis
Journal:  Proteins       Date:  2013-12-14

5.  Bifurcated Hydrogen Bonds and the Fold Switching of Lymphotactin.

Authors:  Prabir Khatua; Alan J Ray; Ulrich H E Hansmann
Journal:  J Phys Chem B       Date:  2020-07-15       Impact factor: 2.991

Review 6.  Regulated unfolding of proteins in signaling.

Authors:  Diana M Mitrea; Richard W Kriwacki
Journal:  FEBS Lett       Date:  2013-02-20       Impact factor: 4.124

7.  Allosteric activation of the Par-6 PDZ via a partial unfolding transition.

Authors:  Dustin S Whitney; Francis C Peterson; Evgenii L Kovrigin; Brian F Volkman
Journal:  J Am Chem Soc       Date:  2013-06-12       Impact factor: 15.419

8.  Engineering Metamorphic Chemokine Lymphotactin/XCL1 into the GAG-Binding, HIV-Inhibitory Dimer Conformation.

Authors:  Jamie C Fox; Robert C Tyler; Christina Guzzo; Robbyn L Tuinstra; Francis C Peterson; Paolo Lusso; Brian F Volkman
Journal:  ACS Chem Biol       Date:  2015-09-02       Impact factor: 5.100

9.  Electrostatic optimization of the conformational energy landscape in a metamorphic protein.

Authors:  Robert C Tyler; Jamie C Wieting; Francis C Peterson; Brian F Volkman
Journal:  Biochemistry       Date:  2012-11-02       Impact factor: 3.162

10.  Metamorphic protein IscU changes conformation by cis-trans isomerizations of two peptidyl-prolyl peptide bonds.

Authors:  Ziqi Dai; Marco Tonelli; John L Markley
Journal:  Biochemistry       Date:  2012-11-15       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.